Welcome to the NURA course Tomorrow’s Data, Today: Sunsetting the 2-year Carcinogenicity Assay.

There is a growing consensus among experts that the current carcinogenicity assessment paradigm needs to shift from the traditional 2-year rodent “bioassay” to a more predictive, human-relevant carcinogenicity assessment. This course features international experts from regulatory, industry, and academic backgrounds working to achieve that goal.

In this training course, hear directly from experts covering current progress among working groups, AOPs and IATAs, case studies, and promising technologies to use in weight-of-evidence carcinogenicity assessments.

In this introduction video, Eryn Slankster-Schmierer, PhD, Physicians Committee for Responsible Medicine, presents the regulatory context for carcinogenicity testing.

Speakers:

Eryn Slankster-Schmierer, PhD, Physicians Committee for Responsible Medicine, Moderator

Tim McGovern, PhD, CDER, US FDA

Joseph Manuppello, Physicians Committee for Responsible Medicine

Connie Mitchell, MS, HESI Workgroup

Gina Hilton, PhD, PSCI

Sarah Dobreniecki, PhD, OPP, US EPA

Susanne Stalford, PhD, Lhasa Ltd

Mirjam Luijten, PhD, RIVM, EPAA Workgroup

Chris Corton, PhD, ORD, US EPA

Annamaria Colacci, PhD, University of Bologna

Ting Li, PhD, NCTR, FDA

Carole Yauk, PhD, University of Ottawa

The videos in this course are available with English and Spanish subtitles. To access these, select the "Settings" (gear) icon within the video.